IMMUNOTHERAPY IN THE TREATMENT OF CANCER: RECENT ADVANCES AND FUTURE DIRECTIONS IN ONCOLOGY

Abstract

Immunotherapy has emerged as an innovative therapeutic strategy in cancer treatment, harnessing the mechanisms of the immune system to combat tumor cells. The purpose of this study is to highlight recent advances and future directions in immunotherapy oncology. Significant advances have been made with the development of immune checkpoint inhibitors, such as anti-PD-1/PD-L1 and anti-CTLA-4 antibodies, which have demonstrated efficacy in several types of cancer, including melanoma, lung cancer, and breast cancer. bladder. Immunotherapy has also been combined with other treatment modalities, such as chemotherapy and targeted therapies, to improve clinical outcomes. However, challenges remain, including treatment resistance, immune-mediated toxicity, and the need to identify more robust predictive biomarkers. Future directions in research include the development of personalized biomarker-based therapies, modulation of the tumor microenvironment, and continued research into therapeutic combination strategies. These advances and challenges highlight the continued importance of research and innovation in the search for more effective and safer therapies for the treatment of cancer.